Compares treatment options for Thirst
Official title Administration of a 'Thirst Relieve Kit' Versus Placebo in Patients After Hospital-based Bowel Preparation for Colonoscopy and Assessment of Thirst Intensity
ClinicalTrials.gov ID: NCT07699809
What this study is testing
- What it's testing
- The goal of this study is to evaluate whether a "thirst kit" (lemon popsicle) is effective in reducing thirst intensity in patients undergoing hospital bowel preparation for colonoscopy. The study also aims to assess the impact of the thirst kit on associated symptoms and patient satisfaction.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- both sexes
- aged 18 years or older, with clear awareness and good cooperation
- who underwent colonoscopy with hospital bowel preparation
You likely can't join if
- any risk of oral fluid aspiration
- swallowing disorders
- post-operative advanced head and neck surgeries
- advanced head and neck neoplasia, active oral diseases (oral mucosal lesions, stomatitis, among others)
- history of gastric surgeries (gastrectomized, upper gastrointestinal tract surgeries for obesity)
- use of GLP-1 analog medications and derivatives in the last 10 days according to hospital protocol (e.g., semaglutide, liraglutide, dulaglutide...
See the full eligibility criteria
- both sexes
- aged 18 years or older, with clear awareness and good cooperation
- who underwent colonoscopy with hospital bowel preparation
- any risk of oral fluid aspiration
- swallowing disorders
- post-operative advanced head and neck surgeries
- advanced head and neck neoplasia, active oral diseases (oral mucosal lesions, stomatitis, among others)
- history of gastric surgeries (gastrectomized, upper gastrointestinal tract surgeries for obesity)
- use of GLP-1 analog medications and derivatives in the last 10 days according to hospital protocol (e.g., semaglutide, liraglutide, dulaglutide, tirzepatide...)
- history of dementia.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.